))
#033 $GSK’s Zantac Fallout Buried Cancer Risks and Billions in Liability
Manage episode 488909480 series 3655494
Content provided by bullsandbetrayal. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by bullsandbetrayal or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
GlaxoSmithKline $GSK allegedly hid a decades-old report showing its blockbuster drug Zantac could form a cancer-causing compound far beyond safe limits. Now, a securities class action says $GSK misled investors for years while lawsuits mounted. In this explosive episode of Bulls and Betrayal, Anna and Nate expose the cover-up, the internal science, and the $2.3B market hit. For pharma investors, legal junkies, and anyone who’s ever trusted a drug label.
We’re not lawyers or accountants, so don’t take this as legal or financial advice.
🔬 Read the full case at ZLK.com | Follow @bullsandbetrayal
$GSK GlaxoSmithKline Zantac NDMA cancer lawsuit drug recall pharma scandal securities fraud shareholder class action FDA litigation whistleblower toxic risk disclosure Emma Walmsley Rule 10b5
37 episodes
Share
